About Vasomeditech
Vasomeditech is a company. The company has 17 employees as of March 22, 2024. Vasomeditech offers products and services including EECP and SphygmoCor.
- Employees 17 as on 22 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Vaso-Meditech Private Limited
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$388.51 K (USD)36.01as on Mar 31, 2022
-
Net Profit
-$59.47 K (USD)-154.58as on Mar 31, 2022
-
EBITDA
$34.2 K (USD)-55.33as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
17
as on Mar 22, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vasomeditech
Vasomeditech offers a comprehensive portfolio of products and services, including EECP and SphygmoCor.
EECP is offered as a non-invasive treatment for cardiovascular conditions, where it is used to counter heart functions externally and improve blood flow without invasive procedures.
SphygmoCor is employed as a device for assessing arterial functions and providing reports on cardiovascular health, supporting patient evaluations in clinical settings.
Funding Insights of Vasomeditech
Detailed funding history for Vasomeditech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vasomeditech
Investment portfolio details for Vasomeditech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vasomeditech
Detailed financials for Vasomeditech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vasomeditech Comparisons
Peer comparison for Vasomeditech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vasomeditech
Detailed competitors of Vasomeditech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vasomeditech
Complete news archive for Vasomeditech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vasomeditech
As of Mar 22, 2024, the latest employee count at Vasomeditech is 17.
Annual revenue of Vasomeditech is $388.51K as on Mar 31, 2022.
Vasomeditech is recognized for providing non-invasive medical treatments and devices aimed at cardiovascular care, with a focus on EECP therapy that has been approved and studied extensively. The company is associated with historical advancements in India, including government programs and clinical publications, where treatments are delivered to patients with arterial issues or post-surgical needs. Operations are managed through training centers and support services, emphasizing safety and external methods without risks, as evidenced by global trials and patient outcomes.
Vasomeditech offers EECP and SphygmoCor.